U.S. markets open in 5 hours 11 minutes

ResMed Inc. (RMD)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
195.16+2.06 (+1.07%)
At close: 4:00PM EDT

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
858 836 5000

IndustryMedical Instruments & Supplies
Full Time Employees7,770

Key Executives

NameTitlePayExercisedYear Born
Dr. Peter C. Farrell A.M., B.E., Ph.D., BE (Hons), ScD, AMFounder & Non-Exec. Chairman431.8kN/A1942
Mr. Michael J. Farrell BE, SM, MBACEO & Director2.73M5.3M1972
Mr. Robert A. DouglasPres & COO1.99M1.13M1960
Mr. Brett A. SandercockChief Financial Officer907.65kN/A1967
Dr. James R. Hollingshead Ph.D.Pres of Sleep & Respiratory Care Bus.1.27M2.3M1963
Mr. Rajwant Singh SodhiPres of Software as a Service Bus. (SaaS)1.04MN/A1973
Mr. Kaushik GhoshalChief Technology OfficerN/AN/AN/A
Mr. David B. PendarvisChief Admin. Officer, Global Gen. Counsel & Corp. Sec.N/AN/A1959
Ms. Constance C. BienfaitDirector of Investor RelationsN/AN/AN/A
Ms. Amy WakehamVP of Investor Relations & Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Corporate Governance

ResMed Inc.’s ISS Governance QualityScore as of April 30, 2021 is 3. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.